The primary objective of this randomized controlled trial is to evaluate the efficacy of lubiprostone (Amitiza) compared to standard treatment with Senokot for opioid-related constipation in adults hospitalized in an acute inpatient rehabilitation setting following orthopedic surgery.
Adults admitted to RIC following orthopedic procedures who require opioids for pain control and who are experiencing symptoms of constipation.
